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INTRODUCTION
Antibiotic-associated diarrhea or colitis (AAD or AAC) can
be caused by nearly all kinds of antibiotics. While Clostridi-
um difficile is the most frequently identified cause of AAC,
Clostridium perfringens, Staphylococcus aureus, drug-resistant
Salmonella species, and Candida species were reported to cause
AAC (1). Although Pseudomonas aeruginosa is not generally
considered as a cause of AAC, several cases of diarrhea prob-
ably caused by P. aeruginosa have been reported (2-4). We
experienced seven cases of nosocomial diarrhea presumably
caused by P. aeruginosa.
PATIENTS AND METHODS
To investigate the clinical relevance of Pseudomonas-induced
diarrhea, microbiologic reports of stool cultures were reviewed
at a university hospital (Samsung Medical Center, Seoul,
Korea) from January 1997 to June 1999. Stool cultures were
done on blood agar plates and MacConkey agar plates. To
detect etiologic organisms of diarrhea, direct microscopy of
stool, stool cultures for Salmonella and Shigella, and tests for
C. difficile toxin (Vidas
�, bioMerieux, MO, U.S.A.) were
done at the same time. The sensitivity and specificity of
Vidas for C. difficile toxin are higher than 90%. Detection of
enteric virus was not done. Our clinical microbiology isolat-
ed P. aeruginosa, S. aureus, or Candida spp. from stool if they
were the only predominant organisms. P. aeruginosa was
identified by automated MicroScan
� system and Vitek
� sys-
tem. P. aeruginosa was the only predominant organism iso-
lated from stool cultures in seven patients. Medical records
of these patients were reviewed retrospectively. We defined
any diarrhea as nosocomial if the onset was 48 hr or later after
admission.
RESULTS
All of the seven patients had nosocomial diarrhea when P.
aeruginosa was isolated from their stool cultures. Among
seven patients, four were males and three were females. The
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Pseudomonas aeruginosa as a Potential Cause of Antibiotic-
Associated Diarrhea
Although Pseudomonas aeruginosa is not generally considered as a cause of
antibiotic-associated diarrhea, several cases of diarrhea caused by P. aerugi-
nosa have been reported. We experienced seven cases of nosocomial diarrhea
presumably caused by P. aeruginosa, which was the predominant organism iso-
lated from stool cultures. Clostridium difficile toxin was also positive in one patient.
No other potential or recognized enteropathogens were identified from stools.
All patients had underlying diseases and had been receiving antibiotics before
the diarrheal onset. All of the seven P. aeruginosa isolates were resistant to pre-
viously given antibiotics. Diarrhea stopped three days after withdrawal of proba-
ble offending antibiotics without specific treatment in two patients. The other five
patients having continuous diarrhea despite withdrawal of probable offending
antibiotics, were successfully treated with antipseudomonal agents. The median
duration of diarrhea after the initiation of treatment was 6.3 days. These data
suggest that P. aeruginosa can be a potential cause of antibiotic-associated
diarrhea. Further investigations are warranted to evaluate the possible etiologic
role of P. aeruginosa in antibiotic-associated diarrhea. 
Key Words : Pseudomonas aeruginosa; Diarrhea; Colitismedian age of patients was 58 (41-71) yr. All patients had
various underlying diseases: acute myelogenous leukemia,
myelofibrosis, rectal cancer, sepsis, hemorrhagic fever with
renal syndrome, subarachnoid hemorrhage, and rheumatoid
arthritis. The median duration of hospitalization before the
onset of nosocomial diarrhea was 19 (4-148) days (Table 1).
All patients had been receiving antibiotics and median dura-
tion of antibiotics before diarrheal onset was 6 (3-21) days.
No patients had concomitant infections caused by Pseudomonas
other than diarrhea.
All isolates of P. aeruginosa from stool cultures were not
susceptible to previously given antibiotics (Table 2). No other
potential or recognized enteropathogens were identified
from stools except one patient whose stool was also positive
for C. difficile toxin at the same time. Sigmoidoscopy, which
was done in four patients, revealed nonspecific colitis with
edematous, hyperemic mucosa, erosion, and several hemor-
rhagic spots.
Diarrhea stopped three days after withdrawal of probable
offending antibiotics without specific treatment in two
patients. The other five patients with continuous diarrhea
despite withdrawal of probable offending antibiotics, were
treated with antipseudomonal agents (Table 1). The median
duration of diarrhea after the initiation of treatment was 6.3
(1-9) days. Antipseudomonal agents were given 2-4 more
days after resolution of diarrhea. One patient with positive
C. difficile toxin was treated with metronidazole and ami-
kacin. No patient died of AAC.
DISCUSSION
P. aeruginosa is one of the most important nosocomial pa-
thogens. Even though P. aeruginosa is not generally consid-
ered as a cause of AAC, there are evidences that Pseudomonas
can cause the infections of gastrointestinal tracts with diar-
rhea in infants. Pseudomonas septicemia in infants was mani-
fested as necrotizing bowel lesions with a history of diarrhea
(5). There have been some reports on community-acquired
Pseudomonas infection of the gastrointestinal tract causing
diarrhea in infants (6, 7).
Seven patients in the present report developed diarrhea
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Sex/Age (yr) Patients
Underlying diseases and infectious 
diseases
Probable offending
antibiotics 
(duration: days)
C.difficile
Toxin assay*
Antibiotics for AAD
1 M/62 Acute myelogenous leukemia, CRBSI Imipenem (21),
Vancomycin (21)
- Ciprofloxacin
2 F/71 Sepsis Ceftriaxone (4),
+ Amikacin, metronidazole
Imipenem (7)
3 M/48 HFRS, possible sepsis Ceftriaxone (5) ND -
4 M/67 Rectal cancer, perioperative Cefotetan (6) --
prophylactic antibiotics
5 F/41 Subarachnoid hemorrhage, pneumonia Ceftizoxime (19) - Ceftazidime, tobramycin
6 M/59 RA, possible sepsis Cefotetan (3) - Ciprofloxacin
7 F/52 MF, BMT, neutropenic fever Imipenem (5) - Ciprofloxacin
Table 1. Characteristics of the patients
*done at the same time with stool cultures. 
Abbreviations: CRBSI: Catheter-related blood stream infection caused by Staphylococcus aureus, HFRS: Hemorrhagic fever with renal syndrome,
RA: Rheumatoid arthritis, MF: Myelofibrosis, BMT: Bone marrow transplantation, ND: not done.
Sex/
Age
(yr)
Probable
offending
antibiotics
Patients
1 M/62 Imipenem S S R I R S R R R R S I R SSRR
2 F/71 Ceftriaxone S R R R R R R R RRR RR RRRR
3 M/48 Ceftriaxone S R R R R R R R RRSSIRSRR
4 M/67 Cefotetan S S R I R SRSRRSSSSSRS
5 F/41 Ceftizoxime S S R I R S I RRRSSSSSRS
6 M/59 Cefotetan S S R I R S ISRRSSSSSRS
7 F/52 Imipenem S I R I R S R R R R S S R SSRS
Table 2. Antibiograms of Pseudomonas aeruginosa isolated from stool cultures of the patients
SXT: trimethoprim/sulfamethoxazole, TICCV: ticarcillin/clavulanic acid, S: susceptible, I: intermediate, R: resistant.
Resistance pattern
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Vafter the administration of antibiotics and in five patients
thereof, diarrhea persisted without improvement 3-5 days
after cessation of offending antibiotics. Diarrheas in these
five patients were successfully controlled by antipseudomonal
agents. This time sequence of treatment and resolution of
diarrhea raised the probability of P. aeruginosa as the cause of
diarrhea. Porco and Visconte reported a patient with P. aerugi-
nosa-induced enteritis whose symptoms rapidly resolved with
oral ciprofloxacin therapy (4). P. aeruginosa was suggested to
cause diarrhea in a report of 23 patients with diarrhea that
developed after use of antibiotics (3).
The pathogenetic mechanism by which antibiotics cause
AAC is a disturbance of the composition and function of
the normal intestinal flora, followed by an overgrowth of
pathogenic microorganisms. Drug-resistant P. aeruginosa
could be selected by antibiotics. Antibiotic susceptibility
patterns of P. aeruginosa strains in these cases support the
good relationship between antibiotic pressure and selection
of resistant organism (8, 9). Cellular adhesion and cytotoxic
activity of P. aeruginosa could be a putative mechanism of
enterotoxigenicity and Pseudomonas-induced enterocolitis
(3), although no enterotoxin was documented from P. aerug-
inosa isolates in a patient with AAC (2).
For the treatment of Pseudomonas-induced AAC, oral cipro-
floxacin therapy was recommended (4). Other antipseudo-
monal agents, such as ceftazidime, aztreonam, and aminogly-
cosides, seem to be effective based on our experience.
Our data have several limitations because it is a retrospec-
tive study: there are no stool culture data at the time of admis-
sion to assure the nosocomial acquisition of P. aeruginosa; no
follow-up cultures of stool to demonstrate the eradication of
P. aeruginosa after treatment and no bacteriologic study on the
isolated P. aeruginosa is available because the strains were not
saved. However, our data and several other reports suggest
that P. aeruginosa could be a potential cause of AAD on the
basis of the clinical courses. Further investigations are war-
ranted to evaluate the possible etiologic role of P. aeruginosa
in antibiotic-associated diarrhea.
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